Demcizumab, identified as OMP 21M18 and cataloged under CAS registry number 1243262-17-0, is a unique monoclonal protein designed to specifically neutralizing certain effect of angiopoietin- TIE 2. Research https://brendapdmd615506.wikicorrespondence.com/user